Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-017757
Filing Date
2006-03-20
Accepted
2006-03-17 17:42:04
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-1942_110k.htm 10-K 1327685
2 CONSENTS OF EXPERTS AND COUNSEL a06-1942_1ex23d1.htm EX-23.1 2509
3 302 CERTIFICATION a06-1942_1ex31d1.htm EX-31.1 9672
4 302 CERTIFICATION a06-1942_1ex31d2.htm EX-31.2 9842
5 906 CERTIFICATION a06-1942_1ex32d1.htm EX-32.1 4796
6 906 CERTIFICATION a06-1942_1ex32d2.htm EX-32.2 4791
  Complete submission text file 0001104659-06-017757.txt   1360757
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: 10-K | Act: 34 | File No.: 001-12493 | Film No.: 06697026
SIC: 2836 Biological Products, (No Diagnostic Substances)